

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | heme biosynthetic process (GO:0006783) | 9.62537851 |
| 2 | tetrapyrrole biosynthetic process (GO:0033014) | 9.30379320 |
| 3 | erythrocyte maturation (GO:0043249) | 7.98713252 |
| 4 | porphyrin-containing compound metabolic process (GO:0006778) | 7.89021856 |
| 5 | hemoglobin metabolic process (GO:0020027) | 7.47315317 |
| 6 | heme metabolic process (GO:0042168) | 7.21520234 |
| 7 | thrombin receptor signaling pathway (GO:0070493) | 6.33284844 |
| 8 | response to methylmercury (GO:0051597) | 5.96584495 |
| 9 | low-density lipoprotein particle clearance (GO:0034383) | 5.76176820 |
| 10 | erythrocyte development (GO:0048821) | 5.57295393 |
| 11 | regulation of platelet activation (GO:0010543) | 5.56205329 |
| 12 | angiogenesis involved in wound healing (GO:0060055) | 5.24815525 |
| 13 | regulation of platelet aggregation (GO:0090330) | 5.24666333 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 5.22770921 |
| 15 | ovulation from ovarian follicle (GO:0001542) | 5.17871889 |
| 16 | negative regulation of platelet activation (GO:0010544) | 5.08328962 |
| 17 | blood coagulation, intrinsic pathway (GO:0007597) | 5.06359632 |
| 18 | tetrapyrrole metabolic process (GO:0033013) | 5.00825826 |
| 19 | platelet aggregation (GO:0070527) | 4.80856766 |
| 20 | erythrocyte differentiation (GO:0030218) | 4.75724412 |
| 21 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.74047737 |
| 22 | iron ion import (GO:0097286) | 4.71582046 |
| 23 | response to insecticide (GO:0017085) | 4.68864679 |
| 24 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.66980666 |
| 25 | protein neddylation (GO:0045116) | 4.60673080 |
| 26 | response to lead ion (GO:0010288) | 4.59582358 |
| 27 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.58718694 |
| 28 | positive regulation of receptor recycling (GO:0001921) | 4.45738938 |
| 29 | regulation of lipoprotein metabolic process (GO:0050746) | 4.40689193 |
| 30 | thyroid hormone generation (GO:0006590) | 4.25983131 |
| 31 | gas transport (GO:0015669) | 4.12457721 |
| 32 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.04379689 |
| 33 | platelet degranulation (GO:0002576) | 3.97587020 |
| 34 | regulation of integrin activation (GO:0033623) | 3.96495839 |
| 35 | fatty acid transmembrane transport (GO:1902001) | 3.94091085 |
| 36 | myeloid cell development (GO:0061515) | 3.91751968 |
| 37 | one-carbon compound transport (GO:0019755) | 3.89419329 |
| 38 | adenosine receptor signaling pathway (GO:0001973) | 3.89308982 |
| 39 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.82228178 |
| 40 | positive regulation of muscle hypertrophy (GO:0014742) | 3.80871875 |
| 41 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.80871875 |
| 42 | response to arsenic-containing substance (GO:0046685) | 3.80525396 |
| 43 | negative regulation of norepinephrine secretion (GO:0010700) | 3.78675233 |
| 44 | thyroid hormone metabolic process (GO:0042403) | 3.77704801 |
| 45 | regulation of response to osmotic stress (GO:0047484) | 3.77627402 |
| 46 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.74313070 |
| 47 | extracellular fibril organization (GO:0043206) | 3.72184777 |
| 48 | pigment biosynthetic process (GO:0046148) | 3.69305917 |
| 49 | positive regulation of blood coagulation (GO:0030194) | 3.63376226 |
| 50 | positive regulation of hemostasis (GO:1900048) | 3.63376226 |
| 51 | embryonic hemopoiesis (GO:0035162) | 3.62946712 |
| 52 | carnitine shuttle (GO:0006853) | 3.62049580 |
| 53 | positive regulation of mast cell activation (GO:0033005) | 3.59124738 |
| 54 | ovulation (GO:0030728) | 3.57876388 |
| 55 | brown fat cell differentiation (GO:0050873) | 3.56999078 |
| 56 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.56181176 |
| 57 | regulation of sequestering of triglyceride (GO:0010889) | 3.54383952 |
| 58 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.53931528 |
| 59 | endothelium development (GO:0003158) | 3.53082933 |
| 60 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.52441347 |
| 61 | triglyceride catabolic process (GO:0019433) | 3.51702524 |
| 62 | regulation of endothelial cell differentiation (GO:0045601) | 3.50337783 |
| 63 | carnitine transmembrane transport (GO:1902603) | 3.46620009 |
| 64 | definitive hemopoiesis (GO:0060216) | 3.44914316 |
| 65 | fibril organization (GO:0097435) | 3.41977079 |
| 66 | valine metabolic process (GO:0006573) | 3.39025023 |
| 67 | bicarbonate transport (GO:0015701) | 3.35142349 |
| 68 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.34470064 |
| 69 | import into cell (GO:0098657) | 3.34426248 |
| 70 | negative regulation of protein localization to cell surface (GO:2000009) | 3.33775143 |
| 71 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.33449963 |
| 72 | platelet activation (GO:0030168) | 3.30478432 |
| 73 | positive regulation of coagulation (GO:0050820) | 3.29572950 |
| 74 | white fat cell differentiation (GO:0050872) | 3.29129605 |
| 75 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.29116692 |
| 76 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.28101888 |
| 77 | negative regulation of stress fiber assembly (GO:0051497) | 3.26071421 |
| 78 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.25493703 |
| 79 | positive regulation of histone deacetylation (GO:0031065) | 3.24354388 |
| 80 | homotypic cell-cell adhesion (GO:0034109) | 3.22336040 |
| 81 | positive regulation of fatty acid oxidation (GO:0046321) | 3.21146344 |
| 82 | regulation of cholesterol storage (GO:0010885) | 3.21017388 |
| 83 | response to folic acid (GO:0051593) | 3.15949904 |
| 84 | fatty acid homeostasis (GO:0055089) | 3.13514773 |
| 85 | carnitine transport (GO:0015879) | 3.13466412 |
| 86 | amino-acid betaine transport (GO:0015838) | 3.13466412 |
| 87 | actin filament capping (GO:0051693) | 3.11489359 |
| 88 | negative regulation of granulocyte differentiation (GO:0030853) | 3.10499217 |
| 89 | regulation of female receptivity (GO:0045924) | 3.06926968 |
| 90 | platelet formation (GO:0030220) | 3.06532970 |
| 91 | neutral lipid catabolic process (GO:0046461) | 3.05343495 |
| 92 | acylglycerol catabolic process (GO:0046464) | 3.05343495 |
| 93 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.05284429 |
| 94 | negative regulation of heart rate (GO:0010459) | 3.03373291 |
| 95 | neutrophil activation (GO:0042119) | 3.03149759 |
| 96 | regulation of hemostasis (GO:1900046) | 3.03051441 |
| 97 | regulation of blood coagulation (GO:0030193) | 3.03051441 |
| 98 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.02840527 |
| 99 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.02027339 |
| 100 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.00084713 |
| 101 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.98702668 |
| 102 | low-density lipoprotein particle remodeling (GO:0034374) | 2.98615945 |
| 103 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.97047551 |
| 104 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.96491993 |
| 105 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.96491993 |
| 106 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.93831425 |
| 107 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.93788619 |
| 108 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.93044721 |
| 109 | regulation of receptor recycling (GO:0001919) | 2.92614315 |
| 110 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.91697421 |
| 111 | pigment metabolic process (GO:0042440) | 2.91137089 |
| 112 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.90266270 |
| 113 | mesodermal cell differentiation (GO:0048333) | 2.89528696 |
| 114 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.87929902 |
| 115 | positive regulation of macrophage differentiation (GO:0045651) | 2.86637742 |
| 116 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.85064506 |
| 117 | fibroblast migration (GO:0010761) | 2.84904459 |
| 118 | positive regulation of macrophage cytokine production (GO:0060907) | 2.84131034 |
| 119 | cellular response to epinephrine stimulus (GO:0071872) | 2.83674068 |
| 120 | lipoxygenase pathway (GO:0019372) | 2.82601236 |
| 121 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.81683024 |
| 122 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.81016682 |
| 123 | positive regulation of p38MAPK cascade (GO:1900745) | 2.80377517 |
| 124 | plasma lipoprotein particle assembly (GO:0034377) | 2.78955559 |
| 125 | relaxation of smooth muscle (GO:0044557) | 2.77819047 |
| 126 | hemidesmosome assembly (GO:0031581) | 2.77222743 |
| 127 | regulation of coagulation (GO:0050818) | 2.77190698 |
| 128 | negative regulation of viral entry into host cell (GO:0046597) | 2.76597471 |
| 129 | biotin metabolic process (GO:0006768) | 2.76569620 |
| 130 | cofactor biosynthetic process (GO:0051188) | 2.76239581 |
| 131 | growth hormone receptor signaling pathway (GO:0060396) | 2.75890248 |
| 132 | negative regulation of heart contraction (GO:0045822) | 2.74664996 |
| 133 | cellular response to dexamethasone stimulus (GO:0071549) | 2.73857211 |
| 134 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.73581088 |
| 135 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.72474929 |
| 136 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.72346076 |
| 137 | negative regulation of adherens junction organization (GO:1903392) | 2.69703663 |
| 138 | negative regulation of focal adhesion assembly (GO:0051895) | 2.69703663 |
| 139 | negative regulation of cell junction assembly (GO:1901889) | 2.69703663 |
| 140 | antibacterial humoral response (GO:0019731) | 2.68640668 |
| 141 | regulation of sarcomere organization (GO:0060297) | 2.68168958 |
| 142 | regulation of muscle hypertrophy (GO:0014743) | 2.67918694 |
| 143 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.66906854 |
| 144 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.66697049 |
| 145 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.66378213 |
| 146 | regulation of renal sodium excretion (GO:0035813) | 2.65592857 |
| 147 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.65550349 |
| 148 | termination of signal transduction (GO:0023021) | 2.65487790 |
| 149 | glomerular filtration (GO:0003094) | 2.61819983 |
| 150 | lysine catabolic process (GO:0006554) | 2.61706325 |
| 151 | lysine metabolic process (GO:0006553) | 2.61706325 |
| 152 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.59701455 |
| 153 | response to epinephrine (GO:0071871) | 2.59646583 |
| 154 | granulocyte activation (GO:0036230) | 2.58889770 |
| 155 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.58832656 |
| 156 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.58502463 |
| 157 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.58457525 |
| 158 | innate immune response in mucosa (GO:0002227) | 2.58385547 |
| 159 | response to dexamethasone (GO:0071548) | 2.58232091 |
| 160 | regulation of DNA endoreduplication (GO:0032875) | 2.58222418 |
| 161 | regulation of pigment cell differentiation (GO:0050932) | 2.57929110 |
| 162 | negative regulation of hemostasis (GO:1900047) | 2.56971041 |
| 163 | negative regulation of blood coagulation (GO:0030195) | 2.56971041 |
| 164 | lipid particle organization (GO:0034389) | 2.55832280 |
| 165 | phospholipid homeostasis (GO:0055091) | 2.55668031 |
| 166 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.55595865 |
| 167 | megakaryocyte development (GO:0035855) | 2.55240205 |
| 168 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.54819643 |
| 169 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.54683556 |
| 170 | peptide catabolic process (GO:0043171) | 2.54513183 |
| 171 | fatty acid beta-oxidation (GO:0006635) | 2.53630497 |
| 172 | cellular response to interferon-alpha (GO:0035457) | 2.53348728 |
| 173 | cGMP biosynthetic process (GO:0006182) | 2.52372250 |
| 174 | plasma lipoprotein particle clearance (GO:0034381) | 2.52287841 |
| 175 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.51906082 |
| 176 | renal filtration (GO:0097205) | 2.50977362 |
| 177 | positive regulation of B cell mediated immunity (GO:0002714) | 2.49893376 |
| 178 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.49893376 |
| 179 | negative regulation of gluconeogenesis (GO:0045721) | 2.49761140 |
| 180 | female mating behavior (GO:0060180) | 2.49124041 |
| 181 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.49051066 |
| 182 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.48957496 |
| 183 | negative regulation of appetite (GO:0032099) | 2.48512973 |
| 184 | negative regulation of response to food (GO:0032096) | 2.48512973 |
| 185 | negative regulation of actin filament depolymerization (GO:0030835) | 2.47720046 |
| 186 | positive regulation of wound healing (GO:0090303) | 2.46594678 |
| 187 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.44748590 |
| 188 | cellular response to growth hormone stimulus (GO:0071378) | 2.44269507 |
| 189 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.42319470 |
| 190 | antimicrobial humoral response (GO:0019730) | 2.40463123 |
| 191 | hemopoiesis (GO:0030097) | 2.40319065 |
| 192 | positive regulation of glucose import (GO:0046326) | 2.39200117 |
| 193 | protoporphyrinogen IX metabolic process (GO:0046501) | 15.3530000 |
| 194 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 14.2531471 |
| 195 | porphyrin-containing compound biosynthetic process (GO:0006779) | 10.4163299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 7.00308844 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.39005622 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.37680912 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.75276902 |
| 5 | GATA1_19941826_ChIP-Seq_K562_Human | 4.49420070 |
| 6 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 3.95955072 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.86368121 |
| 8 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 3.58318708 |
| 9 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 3.35592980 |
| 10 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.35542068 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.18703639 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.98176695 |
| 13 | GATA2_19941826_ChIP-Seq_K562_Human | 2.84703055 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.72179361 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.71145979 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.54237652 |
| 17 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.47151499 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.44175053 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.37525759 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.36277238 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.33324342 |
| 22 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.30495232 |
| 23 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.25900224 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.22028145 |
| 25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.11693061 |
| 26 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.98332030 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.92980727 |
| 28 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.88726430 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.87548279 |
| 30 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.84639609 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84512318 |
| 32 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78286161 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76110831 |
| 34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.74229058 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.71537129 |
| 36 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.64840113 |
| 37 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.60560234 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.57393603 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.56603668 |
| 40 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.55561577 |
| 41 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.55561577 |
| 42 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.55290330 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.54151189 |
| 44 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.54137769 |
| 45 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.52083440 |
| 46 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51472521 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51001552 |
| 48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49758202 |
| 49 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.48097783 |
| 50 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47085780 |
| 51 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.46361506 |
| 52 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.46129507 |
| 53 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.44407793 |
| 54 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42299464 |
| 55 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40398702 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36189251 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.34814964 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.33524508 |
| 59 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.33011918 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32775752 |
| 61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.31822626 |
| 62 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.29693933 |
| 63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29356248 |
| 64 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25540154 |
| 65 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24291067 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23945122 |
| 67 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23811118 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22734083 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.22644022 |
| 70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21500048 |
| 71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18771616 |
| 72 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.18693868 |
| 73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18269589 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17606765 |
| 75 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17349910 |
| 76 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17349910 |
| 77 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15960340 |
| 78 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.15247171 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14585792 |
| 80 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13654650 |
| 81 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12955831 |
| 82 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.12737783 |
| 83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12365927 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11988754 |
| 85 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.10770649 |
| 86 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.07658238 |
| 87 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.06513743 |
| 88 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06264519 |
| 89 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.05896693 |
| 90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05730535 |
| 91 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05257304 |
| 92 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05079023 |
| 93 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05029215 |
| 94 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.04454750 |
| 95 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04447808 |
| 96 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.04425969 |
| 97 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04302071 |
| 98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04190593 |
| 99 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04034506 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.03097435 |
| 101 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01643069 |
| 102 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00962176 |
| 103 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00850410 |
| 104 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00825694 |
| 105 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.00005480 |
| 106 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99833881 |
| 107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99722081 |
| 108 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99060740 |
| 109 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98365614 |
| 110 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96991938 |
| 111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94492961 |
| 112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94465113 |
| 113 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.93838173 |
| 114 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93609651 |
| 115 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93254426 |
| 116 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93106806 |
| 117 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92668705 |
| 118 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.92138898 |
| 119 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91901978 |
| 120 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91792827 |
| 121 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.90873120 |
| 122 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89723473 |
| 123 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.89199715 |
| 124 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89006249 |
| 125 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88858107 |
| 126 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88144329 |
| 127 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87488133 |
| 128 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87139885 |
| 129 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86961049 |
| 130 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86155893 |
| 131 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85935303 |
| 132 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.85430738 |
| 133 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84657631 |
| 134 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.83596502 |
| 135 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83482759 |
| 136 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83130357 |
| 137 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.82855535 |
| 138 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.82393904 |
| 139 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.82393904 |
| 140 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.82304596 |
| 141 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80193280 |
| 142 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.79398350 |
| 143 | MAF_26560356_Chip-Seq_TH1_Human | 0.79358504 |
| 144 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79207940 |
| 145 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79100374 |
| 146 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.77815496 |
| 147 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77525035 |
| 148 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.77385759 |
| 149 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.76963175 |
| 150 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.76256943 |
| 151 | KDM2B_26808549_Chip-Seq_K562_Human | 0.75697449 |
| 152 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75605944 |
| 153 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75508016 |
| 154 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.73993396 |
| 155 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.73018136 |
| 156 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.72995213 |
| 157 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.72976619 |
| 158 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.72710254 |
| 159 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.70861651 |
| 160 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69753886 |
| 161 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.68766995 |
| 162 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.67633681 |
| 163 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.67499932 |
| 164 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.66666615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 8.29580631 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 7.56089448 |
| 3 | MP0008004_abnormal_stomach_pH | 6.26703431 |
| 4 | MP0005670_abnormal_white_adipose | 3.73761215 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.32450448 |
| 6 | MP0000465_gastrointestinal_hemorrhage | 3.24075196 |
| 7 | MP0004510_myositis | 3.11689991 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.04180198 |
| 9 | MP0004130_abnormal_muscle_cell | 3.01734305 |
| 10 | MP0005666_abnormal_adipose_tissue | 2.61489706 |
| 11 | MP0002254_reproductive_system_inflammat | 2.59347666 |
| 12 | MP0004185_abnormal_adipocyte_glucose | 2.33520563 |
| 13 | MP0003303_peritoneal_inflammation | 2.32304056 |
| 14 | MP0008775_abnormal_heart_ventricle | 2.31319971 |
| 15 | MP0005275_abnormal_skin_tensile | 2.30309523 |
| 16 | MP0005167_abnormal_blood-brain_barrier | 2.13569604 |
| 17 | MP0004215_abnormal_myocardial_fiber | 2.12071571 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.07260523 |
| 19 | MP0001545_abnormal_hematopoietic_system | 2.05834395 |
| 20 | MP0005397_hematopoietic_system_phenotyp | 2.05834395 |
| 21 | MP0000230_abnormal_systemic_arterial | 1.95778180 |
| 22 | MP0005375_adipose_tissue_phenotype | 1.90381503 |
| 23 | MP0003828_pulmonary_edema | 1.75709725 |
| 24 | MP0001851_eye_inflammation | 1.75500990 |
| 25 | MP0005083_abnormal_biliary_tract | 1.66384522 |
| 26 | MP0001835_abnormal_antigen_presentation | 1.64409473 |
| 27 | MP0000249_abnormal_blood_vessel | 1.64270693 |
| 28 | MP0010368_abnormal_lymphatic_system | 1.61553677 |
| 29 | MP0004084_abnormal_cardiac_muscle | 1.53684974 |
| 30 | MP0003638_abnormal_response/metabolism_ | 1.44177288 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.43565624 |
| 32 | MP0003879_abnormal_hair_cell | 1.43541694 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.42121918 |
| 34 | MP0004272_abnormal_basement_membrane | 1.40726820 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.38597005 |
| 36 | MP0000003_abnormal_adipose_tissue | 1.37718608 |
| 37 | MP0006054_spinal_hemorrhage | 1.37297954 |
| 38 | MP0009115_abnormal_fat_cell | 1.31139732 |
| 39 | MP0000685_abnormal_immune_system | 1.30149022 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.29519462 |
| 41 | MP0005334_abnormal_fat_pad | 1.27440460 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.25884056 |
| 43 | MP0003091_abnormal_cell_migration | 1.25553191 |
| 44 | MP0009278_abnormal_bone_marrow | 1.21920921 |
| 45 | MP0010329_abnormal_lipoprotein_level | 1.21743932 |
| 46 | MP0001544_abnormal_cardiovascular_syste | 1.21485267 |
| 47 | MP0005385_cardiovascular_system_phenoty | 1.21485267 |
| 48 | MP0010386_abnormal_urinary_bladder | 1.21070701 |
| 49 | MP0001661_extended_life_span | 1.20249680 |
| 50 | MP0000681_abnormal_thyroid_gland | 1.18707696 |
| 51 | MP0003436_decreased_susceptibility_to | 1.18304325 |
| 52 | MP0002736_abnormal_nociception_after | 1.18050787 |
| 53 | MP0002972_abnormal_cardiac_muscle | 1.18040838 |
| 54 | MP0005330_cardiomyopathy | 1.15996797 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.15267651 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.14700400 |
| 57 | MP0002971_abnormal_brown_adipose | 1.13666877 |
| 58 | MP0000749_muscle_degeneration | 1.13501391 |
| 59 | MP0002060_abnormal_skin_morphology | 1.12327926 |
| 60 | MP0005409_darkened_coat_color | 1.11347773 |
| 61 | MP0003111_abnormal_nucleus_morphology | 1.10983742 |
| 62 | MP0004883_abnormal_blood_vessel | 1.08645943 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.07447201 |
| 64 | MP0002970_abnormal_white_adipose | 1.06762892 |
| 65 | MP0000013_abnormal_adipose_tissue | 1.05906728 |
| 66 | MP0005165_increased_susceptibility_to | 1.05616847 |
| 67 | MP0002009_preneoplasia | 1.04663727 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.04626219 |
| 69 | MP0010630_abnormal_cardiac_muscle | 1.04116095 |
| 70 | MP0000343_altered_response_to | 1.04096643 |
| 71 | MP0003950_abnormal_plasma_membrane | 1.03972421 |
| 72 | MP0003724_increased_susceptibility_to | 1.03437939 |
| 73 | MP0003045_fibrosis | 1.02064338 |
| 74 | MP0005387_immune_system_phenotype | 1.01043509 |
| 75 | MP0001790_abnormal_immune_system | 1.01043509 |
| 76 | MP0000609_abnormal_liver_physiology | 1.00884937 |
| 77 | MP0000751_myopathy | 1.00466073 |
| 78 | MP0002006_tumorigenesis | 0.99823737 |
| 79 | MP0006138_congestive_heart_failure | 0.98983206 |
| 80 | MP0004808_abnormal_hematopoietic_stem | 0.98975382 |
| 81 | MP0005595_abnormal_vascular_smooth | 0.98842693 |
| 82 | MP0004484_altered_response_of | 0.98368042 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 0.97772130 |
| 84 | MP0010307_abnormal_tumor_latency | 0.97539911 |
| 85 | MP0005164_abnormal_response_to | 0.97528880 |
| 86 | MP0005620_abnormal_muscle_contractility | 0.97498986 |
| 87 | MP0004947_skin_inflammation | 0.97052948 |
| 88 | MP0008874_decreased_physiological_sensi | 0.96986883 |
| 89 | MP0002876_abnormal_thyroid_physiology | 0.95978950 |
| 90 | MP0005671_abnormal_response_to | 0.95969920 |
| 91 | MP0002295_abnormal_pulmonary_circulatio | 0.95772028 |
| 92 | MP0001800_abnormal_humoral_immune | 0.94536033 |
| 93 | MP0009764_decreased_sensitivity_to | 0.88927255 |
| 94 | MP0001958_emphysema | 0.87261134 |
| 95 | MP0001663_abnormal_digestive_system | 0.86145283 |
| 96 | MP0005410_abnormal_fertilization | 0.83625113 |
| 97 | MP0002723_abnormal_immune_serum | 0.83496862 |
| 98 | MP0005464_abnormal_platelet_physiology | 0.83431181 |
| 99 | MP0004087_abnormal_muscle_fiber | 0.82608654 |
| 100 | MP0002452_abnormal_antigen_presenting | 0.82069151 |
| 101 | MP0009931_abnormal_skin_appearance | 0.81350410 |
| 102 | MP0005501_abnormal_skin_physiology | 0.81038991 |
| 103 | MP0005503_abnormal_tendon_morphology | 0.80895762 |
| 104 | MP0005623_abnormal_meninges_morphology | 0.79627914 |
| 105 | MP0010094_abnormal_chromosome_stability | 0.79569722 |
| 106 | MP0005076_abnormal_cell_differentiation | 0.79155416 |
| 107 | MP0005023_abnormal_wound_healing | 0.78868291 |
| 108 | MP0002118_abnormal_lipid_homeostasis | 0.78402448 |
| 109 | MP0005084_abnormal_gallbladder_morpholo | 0.77944572 |
| 110 | MP0006036_abnormal_mitochondrial_physio | 0.76248364 |
| 111 | MP0000383_abnormal_hair_follicle | 0.74845926 |
| 112 | MP0003567_abnormal_fetal_cardiomyocyte | 0.74831033 |
| 113 | MP0009763_increased_sensitivity_to | 0.74461626 |
| 114 | MP0008995_early_reproductive_senescence | 0.72526491 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.71796722 |
| 116 | MP0002877_abnormal_melanocyte_morpholog | 0.71040733 |
| 117 | MP0001756_abnormal_urination | 0.70997255 |
| 118 | MP0003300_gastrointestinal_ulcer | 0.70524111 |
| 119 | MP0001664_abnormal_digestion | 0.70262768 |
| 120 | MP0002419_abnormal_innate_immunity | 0.70049105 |
| 121 | MP0003186_abnormal_redox_activity | 0.69340638 |
| 122 | MP0002139_abnormal_hepatobiliary_system | 0.69179878 |
| 123 | MP0000767_abnormal_smooth_muscle | 0.68268429 |
| 124 | MP0006276_abnormal_autonomic_nervous | 0.67687765 |
| 125 | MP0001879_abnormal_lymphatic_vessel | 0.67602926 |
| 126 | MP0001845_abnormal_inflammatory_respons | 0.67537768 |
| 127 | MP0000858_altered_metastatic_potential | 0.67362767 |
| 128 | MP0000266_abnormal_heart_morphology | 0.66831443 |
| 129 | MP0004036_abnormal_muscle_relaxation | 0.66528736 |
| 130 | MP0000689_abnormal_spleen_morphology | 0.65854473 |
| 131 | MP0009642_abnormal_blood_homeostasis | 0.65035853 |
| 132 | MP0002420_abnormal_adaptive_immunity | 0.64424049 |
| 133 | MP0000733_abnormal_muscle_development | 0.63583450 |
| 134 | MP0001727_abnormal_embryo_implantation | 0.63191186 |
| 135 | MP0002429_abnormal_blood_cell | 0.63159425 |
| 136 | MP0002127_abnormal_cardiovascular_syste | 0.62607716 |
| 137 | MP0001819_abnormal_immune_cell | 0.61930987 |
| 138 | MP0002332_abnormal_exercise_endurance | 0.61765804 |
| 139 | MP0003959_abnormal_lean_body | 0.60373652 |
| 140 | MP0009765_abnormal_xenobiotic_induced | 0.60289577 |
| 141 | MP0005390_skeleton_phenotype | 0.59818017 |
| 142 | MP0001614_abnormal_blood_vessel | 0.59752891 |
| 143 | MP0004085_abnormal_heartbeat | 0.59708752 |
| 144 | MP0002398_abnormal_bone_marrow | 0.59544807 |
| 145 | MP0002128_abnormal_blood_circulation | 0.59462911 |
| 146 | MP0000759_abnormal_skeletal_muscle | 0.59445694 |
| 147 | MP0001765_abnormal_ion_homeostasis | 0.59364950 |
| 148 | MP0002132_abnormal_respiratory_system | 0.58794460 |
| 149 | MP0005388_respiratory_system_phenotype | 0.57167084 |
| 150 | MP0002133_abnormal_respiratory_system | 0.57167084 |
| 151 | MP0009643_abnormal_urine_homeostasis | 0.56987441 |
| 152 | MP0010771_integument_phenotype | 0.56398083 |
| 153 | MP0010352_gastrointestinal_tract_polyps | 0.55800396 |
| 154 | MP0005319_abnormal_enzyme/_coenzyme | 0.55743373 |
| 155 | MP0005452_abnormal_adipose_tissue | 0.55721125 |
| 156 | MP0000598_abnormal_liver_morphology | 0.54168439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Menorrhagia (HP:0000132) | 9.70591418 |
| 2 | Petechiae (HP:0000967) | 8.44707830 |
| 3 | Purpura (HP:0000979) | 7.97106270 |
| 4 | Hypochromic microcytic anemia (HP:0004840) | 7.51661456 |
| 5 | Acanthocytosis (HP:0001927) | 7.46011853 |
| 6 | Gingival bleeding (HP:0000225) | 6.82301643 |
| 7 | Reticulocytosis (HP:0001923) | 6.41164391 |
| 8 | Cholelithiasis (HP:0001081) | 5.91751038 |
| 9 | Abnormal platelet function (HP:0011869) | 5.44297261 |
| 10 | Impaired platelet aggregation (HP:0003540) | 5.44297261 |
| 11 | Spontaneous hematomas (HP:0007420) | 5.31848497 |
| 12 | Diaphragmatic weakness (HP:0009113) | 5.30157028 |
| 13 | Abnormal gallbladder morphology (HP:0012437) | 5.23337296 |
| 14 | Insomnia (HP:0100785) | 4.90732683 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 4.73782109 |
| 16 | Abnormality of reticulocytes (HP:0004312) | 4.20560966 |
| 17 | Polycythemia (HP:0001901) | 4.05958483 |
| 18 | Hyperbilirubinemia (HP:0002904) | 3.99180871 |
| 19 | Thyroid-stimulating hormone excess (HP:0002925) | 3.93362020 |
| 20 | Paralysis (HP:0003470) | 3.93131706 |
| 21 | Right ventricular cardiomyopathy (HP:0011663) | 3.79974203 |
| 22 | Hypertriglyceridemia (HP:0002155) | 3.77763758 |
| 23 | Osteomalacia (HP:0002749) | 3.55508212 |
| 24 | Ileus (HP:0002595) | 3.48606287 |
| 25 | Microcytic anemia (HP:0001935) | 3.47073403 |
| 26 | Bruising susceptibility (HP:0000978) | 3.44572677 |
| 27 | Hypochromic anemia (HP:0001931) | 3.40108810 |
| 28 | Abnormality of the gallbladder (HP:0005264) | 3.39497534 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.38474848 |
| 30 | Conjunctival telangiectasia (HP:0000524) | 3.35638360 |
| 31 | Oligomenorrhea (HP:0000876) | 3.14843214 |
| 32 | Joint hemorrhage (HP:0005261) | 3.14671664 |
| 33 | Onycholysis (HP:0001806) | 3.03049073 |
| 34 | Acanthosis nigricans (HP:0000956) | 3.00246109 |
| 35 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.94219643 |
| 36 | Increased connective tissue (HP:0009025) | 2.90447011 |
| 37 | Abnormal pupillary function (HP:0007686) | 2.87718298 |
| 38 | Dyschromatopsia (HP:0007641) | 2.79610383 |
| 39 | Ventricular tachycardia (HP:0004756) | 2.78009298 |
| 40 | Cerebral aneurysm (HP:0004944) | 2.75077887 |
| 41 | Cutaneous photosensitivity (HP:0000992) | 2.71298709 |
| 42 | Nausea (HP:0002018) | 2.70659376 |
| 43 | Congenital sensorineural hearing impairment (HP:0008527) | 2.68871222 |
| 44 | Goiter (HP:0000853) | 2.65111189 |
| 45 | Prolonged bleeding time (HP:0003010) | 2.64865476 |
| 46 | Lipoatrophy (HP:0100578) | 2.62818527 |
| 47 | Abnormal gallbladder physiology (HP:0012438) | 2.62352233 |
| 48 | Cholecystitis (HP:0001082) | 2.62352233 |
| 49 | Increased density of long bones (HP:0006392) | 2.60169513 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.56291729 |
| 51 | Aortic aneurysm (HP:0004942) | 2.42323643 |
| 52 | Thyroid carcinoma (HP:0002890) | 2.37589157 |
| 53 | Ventricular fibrillation (HP:0001663) | 2.31162005 |
| 54 | Hemorrhage of the eye (HP:0011885) | 2.29812562 |
| 55 | Broad metatarsal (HP:0001783) | 2.26204716 |
| 56 | Arterial thrombosis (HP:0004420) | 2.25681373 |
| 57 | Fragile skin (HP:0001030) | 2.24653129 |
| 58 | Hyperthyroidism (HP:0000836) | 2.23696195 |
| 59 | Increased serum ferritin (HP:0003281) | 2.23619353 |
| 60 | Joint swelling (HP:0001386) | 2.23490580 |
| 61 | Sudden death (HP:0001699) | 2.22742235 |
| 62 | Abnormality of complement system (HP:0005339) | 2.21538860 |
| 63 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 2.19849893 |
| 64 | Upper limb muscle weakness (HP:0003484) | 2.19371222 |
| 65 | Papillary thyroid carcinoma (HP:0002895) | 2.17821751 |
| 66 | Hypoalphalipoproteinemia (HP:0003233) | 2.16525605 |
| 67 | Spontaneous abortion (HP:0005268) | 2.11871941 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09392411 |
| 69 | Rectal prolapse (HP:0002035) | 2.07990644 |
| 70 | Hypoplasia of the iris (HP:0007676) | 2.07720894 |
| 71 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.07395003 |
| 72 | Long foot (HP:0001833) | 2.05864830 |
| 73 | Atrial fibrillation (HP:0005110) | 2.05149849 |
| 74 | Abnormal auditory evoked potentials (HP:0006958) | 2.04385403 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 2.01720602 |
| 76 | Vertigo (HP:0002321) | 2.01654156 |
| 77 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 11.1419639 |
| 78 | Poikilocytosis (HP:0004447) | 10.9139554 |
| 79 | Autoimmune hemolytic anemia (HP:0001890) | 1.98887199 |
| 80 | Increased mean platelet volume (HP:0011877) | 1.98568369 |
| 81 | Glomerulonephritis (HP:0000099) | 1.97907857 |
| 82 | Abnormality of macrophages (HP:0004311) | 1.97735157 |
| 83 | Xanthomatosis (HP:0000991) | 1.97623093 |
| 84 | Myocardial infarction (HP:0001658) | 1.96884416 |
| 85 | Complement deficiency (HP:0004431) | 1.96325447 |
| 86 | High pitched voice (HP:0001620) | 1.95059459 |
| 87 | Toxemia of pregnancy (HP:0100603) | 1.91987529 |
| 88 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.89962510 |
| 89 | Supraventricular arrhythmia (HP:0005115) | 1.88559155 |
| 90 | Broad palm (HP:0001169) | 1.88004885 |
| 91 | Portal hypertension (HP:0001409) | 1.87468638 |
| 92 | Primary atrial arrhythmia (HP:0001692) | 1.87329771 |
| 93 | Abnormal platelet volume (HP:0011876) | 1.86888573 |
| 94 | Central scotoma (HP:0000603) | 1.86148566 |
| 95 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85945529 |
| 96 | Abnormality of alanine metabolism (HP:0010916) | 1.85945529 |
| 97 | Hyperalaninemia (HP:0003348) | 1.85945529 |
| 98 | Distal lower limb amyotrophy (HP:0008944) | 1.85856019 |
| 99 | Tinnitus (HP:0000360) | 1.85147238 |
| 100 | Mitral stenosis (HP:0001718) | 1.84749666 |
| 101 | Muscle fiber splitting (HP:0003555) | 1.83624585 |
| 102 | Nephritis (HP:0000123) | 1.82041311 |
| 103 | Abnormal number of erythroid precursors (HP:0012131) | 1.82025493 |
| 104 | Supraventricular tachycardia (HP:0004755) | 1.81608178 |
| 105 | Ankle contracture (HP:0006466) | 1.81517259 |
| 106 | Systemic lupus erythematosus (HP:0002725) | 1.81396266 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81356490 |
| 108 | Aneurysm (HP:0002617) | 1.78441896 |
| 109 | Hyponatremia (HP:0002902) | 1.77302873 |
| 110 | Bundle branch block (HP:0011710) | 1.76600096 |
| 111 | Osteolytic defects of the hand bones (HP:0009699) | 1.75050314 |
| 112 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.75050314 |
| 113 | Scapular winging (HP:0003691) | 1.72316433 |
| 114 | Pustule (HP:0200039) | 1.72080559 |
| 115 | Chest pain (HP:0100749) | 1.71644636 |
| 116 | Cortical dysplasia (HP:0002539) | 1.71569821 |
| 117 | Hypoglycemic coma (HP:0001325) | 1.71474878 |
| 118 | Prenatal maternal abnormality (HP:0002686) | 1.69203090 |
| 119 | Large hands (HP:0001176) | 1.68817268 |
| 120 | Hyporeflexia of lower limbs (HP:0002600) | 1.68789547 |
| 121 | Dilated cardiomyopathy (HP:0001644) | 1.67163261 |
| 122 | Duplicated collecting system (HP:0000081) | 1.66682054 |
| 123 | Short middle phalanx of the 5th finger (HP:0004220) | 1.66259447 |
| 124 | Myoglobinuria (HP:0002913) | 1.65628402 |
| 125 | Decreased central vision (HP:0007663) | 1.65139281 |
| 126 | Abnormality of the hepatic vasculature (HP:0006707) | 1.64988404 |
| 127 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.64913951 |
| 128 | Urticaria (HP:0001025) | 1.64614309 |
| 129 | Aortic dissection (HP:0002647) | 1.64483809 |
| 130 | Abnormality of sodium homeostasis (HP:0010931) | 1.62977760 |
| 131 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.62042723 |
| 132 | Striae distensae (HP:0001065) | 1.61547721 |
| 133 | Testicular neoplasm (HP:0010788) | 1.61126388 |
| 134 | Palpitations (HP:0001962) | 1.60238421 |
| 135 | Multiple enchondromatosis (HP:0005701) | 1.60208581 |
| 136 | Growth hormone excess (HP:0000845) | 1.60042559 |
| 137 | Hematochezia (HP:0002573) | 1.59156503 |
| 138 | Abnormality of the nasal mucosa (HP:0000433) | 1.59093640 |
| 139 | Renal tubular acidosis (HP:0001947) | 1.58873014 |
| 140 | Abnormality of lateral ventricle (HP:0030047) | 1.58556178 |
| 141 | Mitral valve prolapse (HP:0001634) | 1.58404457 |
| 142 | Childhood onset (HP:0011463) | 1.58277236 |
| 143 | Elfin facies (HP:0004428) | 1.58271395 |
| 144 | Biliary tract neoplasm (HP:0100574) | 1.58209019 |
| 145 | Difficulty running (HP:0009046) | 1.58190571 |
| 146 | Hyperacusis (HP:0010780) | 1.56030950 |
| 147 | Abnormality of the fingertips (HP:0001211) | 1.55782041 |
| 148 | Nasolacrimal duct obstruction (HP:0000579) | 1.55093930 |
| 149 | Cerebral palsy (HP:0100021) | 1.54922382 |
| 150 | Esophageal varix (HP:0002040) | 1.54004036 |
| 151 | Enlarged penis (HP:0000040) | 1.52308251 |
| 152 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.51271941 |
| 153 | Dilatation of the ascending aorta (HP:0005111) | 1.51150209 |
| 154 | Thrombophlebitis (HP:0004418) | 1.50311144 |
| 155 | Syncope (HP:0001279) | 1.50265561 |
| 156 | Epistaxis (HP:0000421) | 1.49686486 |
| 157 | Thrombocytosis (HP:0001894) | 1.46432532 |
| 158 | Gastrointestinal dysmotility (HP:0002579) | 1.45694351 |
| 159 | Male infertility (HP:0003251) | 1.45035506 |
| 160 | Eczematoid dermatitis (HP:0000976) | 1.43612903 |
| 161 | Increased IgM level (HP:0003496) | 1.41303587 |
| 162 | Arthropathy (HP:0003040) | 1.40896710 |
| 163 | Cerebral ischemia (HP:0002637) | 1.40860685 |
| 164 | Basal ganglia calcification (HP:0002135) | 1.36176739 |
| 165 | Abnormal ciliary motility (HP:0012262) | 1.35923122 |
| 166 | Distal lower limb muscle weakness (HP:0009053) | 1.35783161 |
| 167 | Lower limb amyotrophy (HP:0007210) | 1.34997269 |
| 168 | Arthralgia (HP:0002829) | 1.34491803 |
| 169 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.33290033 |
| 170 | Episodic fever (HP:0001954) | 1.30688368 |
| 171 | Difficulty walking (HP:0002355) | 1.30454151 |
| 172 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.30209352 |
| 173 | Hepatosplenomegaly (HP:0001433) | 1.29059404 |
| 174 | Cerebral hemorrhage (HP:0001342) | 1.28770941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 4.51681381 |
| 2 | RIPK4 | 4.26022572 |
| 3 | MST4 | 3.85303410 |
| 4 | TRIB3 | 3.29882849 |
| 5 | TEC | 3.20250126 |
| 6 | ZAK | 3.14374395 |
| 7 | EIF2AK1 | 2.98344069 |
| 8 | STK4 | 2.93368231 |
| 9 | BMX | 2.91991610 |
| 10 | CAMK1G | 2.89926001 |
| 11 | TLK1 | 2.80700362 |
| 12 | PKN2 | 2.53721926 |
| 13 | PIK3CG | 2.52554754 |
| 14 | TTN | 2.51275342 |
| 15 | EEF2K | 2.50592639 |
| 16 | CDK12 | 2.42418506 |
| 17 | LMTK2 | 2.39738221 |
| 18 | BTK | 2.38427390 |
| 19 | TAOK3 | 2.35402391 |
| 20 | SIK1 | 2.20422344 |
| 21 | TIE1 | 2.18192228 |
| 22 | TGFBR2 | 2.03189408 |
| 23 | EPHA3 | 1.96564660 |
| 24 | BMPR2 | 1.92136416 |
| 25 | CSF1R | 1.73278809 |
| 26 | CDK9 | 1.70494162 |
| 27 | STK10 | 1.62394946 |
| 28 | TRPM7 | 1.61309611 |
| 29 | ZAP70 | 1.60667775 |
| 30 | GRK5 | 1.57571237 |
| 31 | STK24 | 1.53860790 |
| 32 | RIPK1 | 1.49771773 |
| 33 | PDK3 | 1.43131723 |
| 34 | PDK4 | 1.43131723 |
| 35 | RPS6KB2 | 1.41192842 |
| 36 | VRK1 | 1.40975118 |
| 37 | FES | 1.40554088 |
| 38 | HCK | 1.40049712 |
| 39 | BLK | 1.32859763 |
| 40 | MAP3K10 | 1.32772488 |
| 41 | PRKAA2 | 1.31919553 |
| 42 | FER | 1.30237452 |
| 43 | BCKDK | 1.30213073 |
| 44 | CDK6 | 1.28327456 |
| 45 | NLK | 1.26192663 |
| 46 | ITK | 1.24588693 |
| 47 | CDC7 | 1.23066130 |
| 48 | ACVR1B | 1.22315713 |
| 49 | IRAK1 | 1.17839246 |
| 50 | RPS6KA5 | 1.17798349 |
| 51 | INSRR | 1.14141911 |
| 52 | JAK2 | 1.13429061 |
| 53 | LATS1 | 1.13113445 |
| 54 | CSK | 1.12643733 |
| 55 | PRKAA1 | 1.11941656 |
| 56 | MAPK11 | 1.09372283 |
| 57 | STK3 | 1.08668295 |
| 58 | FGR | 1.08475857 |
| 59 | FLT3 | 1.08118757 |
| 60 | DAPK3 | 1.06309605 |
| 61 | PIK3CA | 1.06185292 |
| 62 | NEK9 | 1.02125496 |
| 63 | CDK4 | 1.00058507 |
| 64 | SGK2 | 0.99192786 |
| 65 | MAP2K3 | 0.98956132 |
| 66 | LRRK2 | 0.96726405 |
| 67 | MAP3K5 | 0.95524938 |
| 68 | EIF2AK2 | 0.91398034 |
| 69 | MAP3K8 | 0.91155504 |
| 70 | MAPK12 | 0.90211398 |
| 71 | FGFR3 | 0.88718058 |
| 72 | JAK1 | 0.87174243 |
| 73 | MAPKAPK3 | 0.86953597 |
| 74 | PDPK1 | 0.86599347 |
| 75 | AKT3 | 0.86145178 |
| 76 | ERBB2 | 0.85095369 |
| 77 | LYN | 0.84591532 |
| 78 | PIM1 | 0.82738439 |
| 79 | DDR2 | 0.82017772 |
| 80 | AURKB | 0.80666020 |
| 81 | PDGFRA | 0.80591991 |
| 82 | ADRBK1 | 0.80119903 |
| 83 | ADRBK2 | 0.79785110 |
| 84 | MYLK | 0.79573570 |
| 85 | GRK6 | 0.78676210 |
| 86 | PTK2B | 0.78340929 |
| 87 | EPHB1 | 0.78018471 |
| 88 | MST1R | 0.77958475 |
| 89 | PNCK | 0.77629087 |
| 90 | RET | 0.76383340 |
| 91 | IKBKB | 0.76343758 |
| 92 | JAK3 | 0.76320611 |
| 93 | SCYL2 | 0.75957293 |
| 94 | FGFR2 | 0.75371708 |
| 95 | TTK | 0.74917313 |
| 96 | MAP2K1 | 0.74666787 |
| 97 | NEK2 | 0.72662327 |
| 98 | TYK2 | 0.72315129 |
| 99 | CDC42BPA | 0.72241785 |
| 100 | MELK | 0.71998248 |
| 101 | PAK1 | 0.71720134 |
| 102 | MAP3K6 | 0.71537320 |
| 103 | FGFR4 | 0.70925375 |
| 104 | EPHB2 | 0.70467696 |
| 105 | MTOR | 0.70105615 |
| 106 | SGK3 | 0.66623213 |
| 107 | PAK2 | 0.65623038 |
| 108 | BRD4 | 0.65225359 |
| 109 | WNK1 | 0.64995080 |
| 110 | DMPK | 0.64361860 |
| 111 | KDR | 0.63859738 |
| 112 | BRSK1 | 0.63443294 |
| 113 | TNK2 | 0.61537835 |
| 114 | MAPKAPK5 | 0.60121189 |
| 115 | BMPR1B | 0.57751363 |
| 116 | OBSCN | 0.56216501 |
| 117 | DYRK3 | 0.55106036 |
| 118 | FRK | 0.54199752 |
| 119 | MAP3K3 | 0.53610485 |
| 120 | MARK3 | 0.51536730 |
| 121 | ROCK1 | 0.49972333 |
| 122 | LCK | 0.49309194 |
| 123 | PRKACG | 0.49003222 |
| 124 | PHKG2 | 0.48145608 |
| 125 | PHKG1 | 0.48145608 |
| 126 | KIT | 0.45379383 |
| 127 | PRKG1 | 0.45327800 |
| 128 | TNIK | 0.45043872 |
| 129 | STK38L | 0.44344673 |
| 130 | PLK2 | 0.43594895 |
| 131 | NME2 | 0.43512212 |
| 132 | CAMK1 | 0.41749575 |
| 133 | IKBKE | 0.41404904 |
| 134 | PKN1 | 0.40325759 |
| 135 | TXK | 0.40072344 |
| 136 | CHEK2 | 0.40013967 |
| 137 | PRKCH | 0.39891874 |
| 138 | DAPK2 | 0.39837364 |
| 139 | MAP3K7 | 0.39287057 |
| 140 | ATM | 0.39266093 |
| 141 | ERN1 | 0.38445842 |
| 142 | PDGFRB | 0.38106923 |
| 143 | SGK494 | 0.37662961 |
| 144 | SGK223 | 0.37662961 |
| 145 | PIM2 | 0.37437658 |
| 146 | CAMKK2 | 0.36869772 |
| 147 | MET | 0.35838872 |
| 148 | GRK7 | 0.35830547 |
| 149 | NUAK1 | 0.35725635 |
| 150 | FYN | 0.35171991 |
| 151 | IGF1R | 0.34248526 |
| 152 | PTK6 | 0.34180506 |
| 153 | PRKD1 | 0.33573977 |
| 154 | PDK1 | 0.33141519 |
| 155 | TGFBR1 | 0.32061360 |
| 156 | SGK1 | 0.31167562 |
| 157 | SYK | 0.31167545 |
| 158 | MAPK7 | 0.30912510 |
| 159 | MAPKAPK2 | 0.30395208 |
| 160 | ILK | 0.30251408 |
| 161 | PDK2 | 0.30179955 |
| 162 | HIPK2 | 0.29956796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 5.80330720 |
| 2 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 5.63961566 |
| 3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.12262328 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.97971959 |
| 5 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.89539348 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.67321151 |
| 7 | Alcoholism_Homo sapiens_hsa05034 | 2.55807276 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.37360035 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.20302398 |
| 10 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.07639088 |
| 11 | ABC transporters_Homo sapiens_hsa02010 | 2.05044503 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.01297257 |
| 13 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 2.00347648 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91589586 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.88784022 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80858644 |
| 17 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.76352629 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.73665862 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.65959803 |
| 20 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.65448591 |
| 21 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.64921601 |
| 22 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.60980807 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54644760 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54158820 |
| 25 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.53000895 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.50939962 |
| 27 | Gap junction_Homo sapiens_hsa04540 | 1.50272172 |
| 28 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.43175852 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36126678 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.35120640 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.34273078 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.33138977 |
| 33 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.30449023 |
| 34 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.27805959 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24447170 |
| 36 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.24117130 |
| 37 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.22426283 |
| 38 | Insulin resistance_Homo sapiens_hsa04931 | 1.20503168 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17163222 |
| 40 | Focal adhesion_Homo sapiens_hsa04510 | 1.01455591 |
| 41 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.00849378 |
| 42 | Lysine degradation_Homo sapiens_hsa00310 | 0.99553337 |
| 43 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.99170893 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.96936773 |
| 45 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.96671570 |
| 46 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.96103280 |
| 47 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.93270897 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92856411 |
| 49 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92769032 |
| 50 | Cell cycle_Homo sapiens_hsa04110 | 0.92598709 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92484241 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.92312864 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.90554290 |
| 54 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.90324843 |
| 55 | Long-term depression_Homo sapiens_hsa04730 | 0.87498383 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.85446329 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85351851 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84292060 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82729610 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.82013597 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81981083 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.81875989 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80619660 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80448513 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79076977 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79017085 |
| 67 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78143155 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77897136 |
| 69 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.77204934 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.75778061 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.74728140 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.73655289 |
| 73 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73023278 |
| 74 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72994286 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71928092 |
| 76 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71839355 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71642347 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71632855 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71283972 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.70213634 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.69809072 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68364246 |
| 83 | Circadian entrainment_Homo sapiens_hsa04713 | 0.67852480 |
| 84 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67639852 |
| 85 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67546062 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67544009 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66857048 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.66351728 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65694255 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65247147 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63935235 |
| 92 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62661548 |
| 93 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62466652 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60439005 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60105155 |
| 96 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.59303853 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59188518 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58550392 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.58538454 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.58031176 |
| 101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.57194744 |
| 102 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57082629 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56226846 |
| 104 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55994226 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55669298 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55486179 |
| 107 | Glioma_Homo sapiens_hsa05214 | 0.54859049 |
| 108 | Asthma_Homo sapiens_hsa05310 | 0.54858468 |
| 109 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.54825890 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53093174 |
| 111 | Morphine addiction_Homo sapiens_hsa05032 | 0.52651503 |
| 112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52455631 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51011273 |
| 114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50749523 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50353087 |
| 116 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49856394 |
| 117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48726468 |
| 118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48280838 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.48053862 |
| 120 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.47640690 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47225718 |
| 122 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.46883216 |
| 123 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46224040 |
| 124 | Measles_Homo sapiens_hsa05162 | 0.46030598 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44509225 |
| 126 | Allograft rejection_Homo sapiens_hsa05330 | 0.44106692 |
| 127 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44077049 |
| 128 | Pertussis_Homo sapiens_hsa05133 | 0.43654946 |
| 129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43009001 |
| 130 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.42015169 |
| 131 | Hepatitis B_Homo sapiens_hsa05161 | 0.41502523 |
| 132 | DNA replication_Homo sapiens_hsa03030 | 0.40227517 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39908709 |
| 134 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37807496 |
| 135 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.36888977 |
| 136 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35490665 |
| 137 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35418323 |
| 138 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34815805 |
| 139 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.34520228 |
| 140 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33022492 |
| 141 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32185562 |
| 142 | Influenza A_Homo sapiens_hsa05164 | 0.32139614 |
| 143 | Renin secretion_Homo sapiens_hsa04924 | 0.31546900 |
| 144 | Bladder cancer_Homo sapiens_hsa05219 | 0.31359808 |
| 145 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29250771 |
| 146 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28797382 |
| 147 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.28495354 |
| 148 | Hepatitis C_Homo sapiens_hsa05160 | 0.26698231 |
| 149 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.26139309 |
| 150 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24535462 |
| 151 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.23198079 |
| 152 | Peroxisome_Homo sapiens_hsa04146 | 0.22816365 |
| 153 | Melanoma_Homo sapiens_hsa05218 | 0.21253063 |
| 154 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21102988 |
| 155 | Adherens junction_Homo sapiens_hsa04520 | 0.20806498 |
| 156 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.19835034 |
| 157 | Leishmaniasis_Homo sapiens_hsa05140 | 0.19804401 |
| 158 | Pathways in cancer_Homo sapiens_hsa05200 | 0.19620632 |
| 159 | Prostate cancer_Homo sapiens_hsa05215 | 0.19427961 |
| 160 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.18067694 |

